Sign Up to like & get
recommendations!
0
Published in 2025 at "ACS Omega"
DOI: 10.1021/acsomega.5c03248
Abstract: Objective: To address the unmet clinical need for Lysine (K)-specific demethylase 4A (KDM4A)-targeted therapies in nonsmall cell lung cancer (NSCLC), we developed a novel theranostic pair, 68Ga/161Tb-CP2, leveraging the epigenetic regulator KDM4A and terbium-161’s high…
read more here.
Keywords:
cp2;
161tb cp2;
68ga 161tb;
kdm4a ... See more keywords